These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22783443)

  • 1. Arsenic trioxide enhances the cytotoxic effect of cisplatin in head and neck squamous cell carcinoma cell lines.
    Kotowski U; Heiduschka G; Brunner M; Erovic BM; Martinek H; Thurnher D
    Oncol Lett; 2012 Jun; 3(6):1326-1330. PubMed ID: 22783443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma.
    Schnoell J; Stanisz I; Jank BJ; Stanek V; Schmid R; Brunner M; Heiduschka G; Kotowski U
    Invest New Drugs; 2022 Apr; 40(2):224-231. PubMed ID: 34613571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial Low Dose Arsenic Trioxide and Cisplatin Exacerbates Autophagy via AMPK/STAT3 Signaling on Targeting Head and Neck Cancer Initiating Cells.
    Hu WC; Teo WH; Huang TF; Lee TC; Lo JF
    Front Oncol; 2020; 10():463. PubMed ID: 32351887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY; Lam SK; Li YY; Fong BM; Mak JC; Ho JC
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antitumor drug F14512 enhances cisplatin and ionizing radiation effects in head and neck squamous carcinoma cell lines.
    Mouawad F; Gros A; Rysman B; Bal-Mahieu C; Bertheau C; Horn S; Sarrazin T; Lartigau E; Chevalier D; Bailly C; Lansiaux A; Meignan S
    Oral Oncol; 2014 Feb; 50(2):113-9. PubMed ID: 24290982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
    Du S; Liu K; Gao P; Li Z; Zheng J
    Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cilengitide in combination with irradiation and chemotherapy in head and neck squamous cell carcinoma cell lines.
    Heiduschka G; Lill C; Schneider S; Seemann R; Kornek G; Schmid R; Kotowski U; Thurnher D
    Strahlenther Onkol; 2014 May; 190(5):472-9. PubMed ID: 24557056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.
    Jiang M; Liu Z; Xiang Y; Ma H; Liu S; Liu Y; Zheng D
    BMC Cancer; 2011 Feb; 11():54. PubMed ID: 21291526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines.
    Enzenhofer E; Kadletz L; Stanisz I; Kotowski U; Seemann R; Schmid R; Thurnher D; Heiduschka G
    Head Neck; 2017 May; 39(5):900-907. PubMed ID: 28170128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of neratinib and combination with irradiation and chemotherapy in head and neck cancer cells.
    Schneider S; Thurnher D; Kadletz L; Seemann R; Brunner M; Kotowski U; Schmid R; Lill C; Heiduschka G
    Oral Dis; 2016 Nov; 22(8):797-804. PubMed ID: 27476950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of thymoquinone on head and neck squamous cell carcinoma cells
    Kotowski U; Heiduschka G; Kadletz L; Fahim T; Seemann R; Schmid R; Schneider S; Mitterbauer A; Thurnher D
    Oncol Lett; 2017 Jul; 14(1):1147-1151. PubMed ID: 28693287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7beta-hydroxycholesterol induces apoptosis and regulates cyclooxygenase 2 in head and neck squamous cell carcinoma.
    Heiduschka G; Erovic BM; Vormittag L; Skoda C; Martinek H; Brunner M; Ehrenberger K; Thurnher D
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):261-7. PubMed ID: 19289704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic trioxide disturbs the LIS1/NDEL1/dynein microtubule dynamic complex by disrupting the CLIP170 zinc finger in head and neck cancer.
    Gao L; Xue B; Xiang B; Liu KJ
    Toxicol Appl Pharmacol; 2020 Sep; 403():115158. PubMed ID: 32717241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HS-173, a selective PI3K inhibitor, induces cell death in head and neck squamous cell carcinoma cell lines.
    Foki E; Stanisz I; Kadletz L; Kotowski U; Seemann R; Schmid R; Heiduschka G
    Wien Klin Wochenschr; 2021 Jan; 133(1-2):26-31. PubMed ID: 32876741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of caroverine as a potential chemotherapeutical agent in HNSCC cell lines.
    Haymerle G; Thurnher D; Kadletz L; Stanisz I; Brunner M; Kotowski U; Enzenhofer E; Heiduschka G
    Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3451-6. PubMed ID: 25351499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AZD5582, an IAP antagonist that leads to apoptosis in head and neck squamous cell carcinoma cell lines and is eligible for combination with irradiation.
    Kadletz L; Enzenhofer E; Kotowski U; Altorjai G; Heiduschka G
    Acta Otolaryngol; 2017 Mar; 137(3):320-325. PubMed ID: 27739348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells.
    Mantha AJ; McFee KE; Niknejad N; Goss G; Lorimer IA; Dimitroulakos J
    J Cancer Res Clin Oncol; 2003 Nov; 129(11):631-41. PubMed ID: 12942316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin Enhances Cisplatin and Radiation Cytotoxicity in Head and Neck Squamous Cell Carcinoma by Stimulating Mitochondrial ROS Generation, Apoptosis, and Autophagy.
    Fernandez-Gil BI; Guerra-Librero A; Shen YQ; Florido J; Martínez-Ruiz L; García-López S; Adan C; Rodríguez-Santana C; Acuña-Castroviejo D; Quiñones-Hinojosa A; Fernández-Martínez J; Abdel Moneim AE; López LC; Rodríguez Ferrer JM; Escames G
    Oxid Med Cell Longev; 2019; 2019():7187128. PubMed ID: 30944696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of arsenic trioxide as a treatment of cisplatin-resistant non-small cell lung cancer PC-9/CDDP and PC-14/CDDP cells.
    Suzuki T; Ishibashi K; Yumoto A; Nishio K; Ogasawara Y
    Oncol Lett; 2015 Aug; 10(2):805-809. PubMed ID: 26622574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synergistic lethal effect of combined treatment of arsenic trioxide and aclacinomycin on human acute myeloid leukemia cell line KG-1a].
    Ye YB; Xu XJ; Chen YH; Zhang MW; Qiu DF; Guo ZW; He HQ
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):256-262. PubMed ID: 28550664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.